Alantra has expertly guided Ypsomed in a strategic move to divest its pen needle and blood glucose monitoring (BGM) divisions to MTD Medical Technology and Devices, an Italy-based firm.
This decision is part of Ypsomed’s strategy to focus more on their innovative mylife Loop insulin pump solution, a key
All the week’s industry events straight to your inbox.
By signing up you agree to our terms of use and privacy policy.
7 Bell Yard, London, England, WC2A 2JR
You will soon receive a Reset Password link
By signing up you agree to terms of use and privacy policy.
Continue with Facebook Continue with Google